throbber
20.
`
`Zl.
`
`22.
`23.
`
`24.
`
`25.
`
`20.
`27.
`
`9568 Biochemistry, Val. 48, No, 40. 2009
`19.
`Hudder, B. N.. Morales, l. G., Stubna, A., Mdnck, 13.. Hendrich,
`M. P., and Lindal'tl, P. A. (2007) Electron paramagnetic resonance
`and Mo'ssbauer spectroscopy of intact mitochondria from rcspiring
`Sacrharamyces television. J. Biol. Inorg. Chem. [2, 10294053.
`Lindahl. P., Morales, l. (3., Miao. 11.. and Holmes-Hampton. G.
`(2009)
`Isolation of Saa‘huwmyce's cerevrlriae mitochondria for
`Miissbaucr, EPR, and electronic absorption spectroscopic analyses.
`Method: Enzyme]. 456, 267~285.
`Schillte, 8.. Voisinc, C.. Eeinert, H.,and Craig. E, (1999) Evidence for
`a conserved system for iron metabolism in the mitochondria of
`Sacchammyces cerevr'sioe. Prat". Natl, Acad. Sci. U.S.A. 96. 102%
`102] l.
`Kohlhuw, G. B. (1988) lsopropylmaiatc dehydratase from yeast.
`Mezhwir Enzyme]. 166. 423429.
`Munujox. P.. Collcanti, .1.. Gomlcmstrc. F., and Gella, 51.11993)
`Assay of suecinatc—dchydrogennse activity by a colorimetric-contin-
`uous method using iodonitrotetrazolium chloride as electron-accep
`tor. Anal. Biochem. 212. 506—509.
`Tamar-it, 3., Irazusta, V.. Morcuo‘Ccrrncno, A... and Ros, J. (2006)
`Calorimetric assay for the quantitation of iron in yeast. Anal.
`Biochem. 351. M97 lsl.
`Poittrkova. A. V., and Rehr. .l.
`.l. (1999) Multiple-scattering bray-
`absorption fine-structure DebyoWaller factor calculations, Phys.
`Rev. 959,948 957.
`Plattner, 1-1., and Schntz, G. (1969) Promitochondria ofanaerobically
`grown yeast. 3. Morphology. Bior'hemorrva. 339 343.
`Kwnst. K. E.. Lai. L. C.. Manda. N, James. D. T.. Aref, 5., and
`Burke, P. V. (2002) Genomicanalyses of anaerobically induced genes
`in Sarclmmmym crrevr'siae: Functional
`roles of Roxl
`and
`other factors in mediating the anoxio response. J. Bactelr'al.
`I84.
`250-265.
`Paltauf, F., and Schatz. 6. (I969) Promitochondria ofanaerobically
`grown yeast. 2. Lipid composition, Biochemirlry 8, 33$339,
`Roscnfeld. E., and Beuuvoil. B. (2003) Role of the non-respiratory
`pathways in the utilization of molecular oxygen by Sacrharamyws
`cerevirr'ae. Your! 20. lllflrl I44.
`Barres, M. H., Nobrega, F. 0.. and Tugolol‘l, A. (2002) Mitochon-
`drial ferredoxm is required for heme A synthesis in Sat-chammyrm
`rerevirr'ae. J. Biol. Chem :77. 9997—10002.
`Bultcnu, A. L., Dancis. A., Gareil. M, Montaigne, l. 1.. Camadra.
`.l. M., and Lesulste, E, (2007) Oxidative stress and protease dysfunc—
`tion in the yeast model of Friedreich ataxia. Free Radical Biol. Merl.
`42,1561 1570.
`Hasxett, R. F., Romeo, A. M., and Kosman, D. J. (1998) Regulation
`of high affinity iron uptake in the yeast Sacchammyces ccrnisiue—
`Role of dioxygen and Fem). J. Biol. Chem. 273, 7628-7636.
`
`28,
`29,
`
`30,
`
`31.
`
`32.
`
`33.
`Sat.
`
`36,
`37.
`38.
`
`_
`
`Jensen. L. T.. and Culottu. V. C. (2002) Regulation ofSarrhammyce:
`i-rrevirr'ur FET4 by oxygen and iron. J. Mal. Biol, 318, 2517260.
`Waters. B. M,, and Eide, D. 1. (2002) Combinatorial control ofyeast
`FET4 gene expression by iron, zinc, and oxygen. .1. Biol, Chem. 277.
`33749733757.
`. Cavadini. R. Biasiotto, 5., Poll. M., Levi. 3., Verardi, R., Lanella, 1.,
`Derosas. M.. lngrassio. R.. Corrado. M., and Arctic, P. (2007) RNA
`silencing of the mitochondrial ABCE7 transporter in HeLa cells
`causes an iron—deficient phenotype with mitochondrial iron overload.
`Blood [09. 355273559.
`Halliwell, B. (2009)"11‘1: wanderings of a free radical. Free Radical
`Biol. Med. 46. 530542.
`lmluy. J. A.
`(2006) iron-sulphur clusters and the problem with
`oxygen. Mal. Microbiol. 59. 10734082.
`Mlihlcnhoff, U.. Richhardt. N.. Gerber, 1.. and Lill, R.
`(2002)
`Characterization of iron-sulfur protein assembly in isolated mito‘
`chondriar‘ult requirement for ATP. NADH, and reduced iron. J. Biol.
`Chem. 277. 2981029816.
`. Rnuen, U.,Spn'ngcr. A,. Weisheit. D.. Petrol. F.. Korth. H. G, deGrool.
`H.. and Sustrnann. R. (2007) Assessment of chelausble mitochondrial
`iron by using mitochondrion-selective fluorescent iron indiarth with
`dill'erent iron-binding allinities. ChmBiaChem 8, 341—352.
`. Cambridge
`Structural Database
`(http://www.ccdc.cam.ac.uk/
`products/csdfl.
`41.
`Wilkinson. E. C.. Dung. Y. H., and Que. L.
`(1994) Modeling
`hydrolysis at dinuclear iron centers. J. Am. Chem. Soc. 116, 8394—
`8395.
`Lange,
`l-l.. Kispal, (L. and Lil], R.
`(1999) Mechanism of iron
`transport to the site of heme synthesis inside yeast mitochondria.
`J. Biol. Chem. 274, l8989718996.
`Lill, 12,, and Miihlenhoft‘. U. (2006) Iron-sulfur protein biogcncsis in
`cukaryotes: Components and mechanisms. Annu. Rev. Cell. Dev. Biol.
`22, 4577486.
`. Schueck. N. D,, Woontner. M., and Koeller, D. M. (2001)The role of
`the mitochondrlon in cellular iron homeostasis. Mimchondrian 1,
`51760.
`Burke, M. A., and Ardehali. H. (2007) Mitochondrial ATP-binding
`cassette proteins. Tram]. Res. [50. 73780.
`. Chen. S.. Sanchez—Fernandez, R., Lyver, F.. R., Dancis, A., and Rea,
`P. A. (2007) Functional characterization ofAlATM 1, AtATMZ, and
`AtATMB, a subfamily of Ambidnpsis half»molecule ATP-binding
`cassette transporters implicated in iron homeostasis. J. Rial. Chem.
`282, 21561r2|57l.
`Liu. W. T.. and Thorp, H. H. (1993) Bond valence sum analysis
`of metal-ligand bond lengths in metallocnzyrrtes and model com-
`plexes 2. Refined distances and other enzymes. Inorg. Chem, 32.
`41024105.
`
`42.
`
`43.
`
`45.
`
`47.
`
`Miao ct a1.
`
`B OCHEMISTRY
`MIWWlmm
`”Article
`
`Biochemistry 2009, 48, 9569.9581
`DOI: 10.1021/bi901182w
`
`9569
`
`The Yeast iron Regulatory Proteins er3/4 and Fra2 Form Heterodimeric Complexes
`Containing a [2Fe-ZS] Cluster with Cysteinyl and Histidyl Ligation:r
`
`Haoran Li} Daphne T. Mapolelo.§ Nin N. Dingrafounil G. Naik," Nicholas S. Lees} Brian M. Hoffman:L
`Pamela J. Riggs-Gelaseof Boi Hanh l-luynh,I Michael K. Johnson,*‘§ and Caryn E. Outten‘“:
`:Department: ofChemistry and Biochemistry. University o/Sourh Carolina. Columbia, South Carolina 29208,
`’Department of Chemistry and Centerfor Metalloenzyme Studies, University of Georgia, A rhenr, Georgia 30602. "Department of
`Physics, Emory University, Atlanta, Georgia 30322, J'Chemistry Department, Northwestern University, Evanston. llll'nols 60208. and
`Department of Chemistry and Biochemistry, College of Charleston. Charleston, Soul/1 Carolina 29424
`Received July 10, 2009: Revised Manuscrr'pr Received A ugusr 28, 2009
`
`ABSTRACT: The transcription of iron uptake and storage genes in Sacrhammycer ccrevisiae is primarily
`regulated by the transcription factor Aftl. Nucleocytoplasmic shuttling of Aftl
`is dependent upon
`mitochondrial Fe-S cluster blosymhesis via a signaling pathway that includes the cytosolic monothiol
`glutaredoxins (er3 and er4) and the ROM homologue Fra2. However, the interactions between these
`proteins and the iron-dependent mechanism by which they control Aftl
`localization are unclear. To
`reconstitute and characterize components of this signaling pathway in virro, we have overexpressed yeast
`Fra2 and er3/4 in Escherichia coli. We have shown that coexpression of recombinant Fra2 with er3 or
`er4 allows purification of a stable [2Fe-ZS]2+ cluster—containing Fra2-er3 or FraZ-er4 heterodimerlc
`complex. Reconstitution of a [ZR->25] cluster on er3 or er4 without FraZ produces a [2Fe—25]~bridgcd
`homodimer. UV—visible absorption and CD, resonance Raman, EPR, ENDOR, Méssbuuer, and EXAFS
`studies of [2Fe-ZS] er3/4 homodimers and the [2Fe-2S] Fra2—er3/4 heterodimers indicate that inclusion of
`Fra2 in the Gl‘X3/4 Fe-S complex causes a change in the cluster stability and coordination environment.
`Taken together, our analytical, spectroscopic, and mutagenesis data indicate that er3/4 and FraZ form a Fc—
`S—bridged heterodimen'c complex with Fe ligands provided by the active site cysteine ofer3/4, glutathione,
`and a histidine residue. Overall, these results suggest that the ability ofthe Fra2-er3/4 complex to assemble a
`[2Fe-ZS] cluster may act as a signal to control the iron regulon in response to cellular iron status in yeast.
`
`Maintenance of optimal iron levels inside the cell is critical for
`all eukaryoles and most prokaryotes, for iron is both essential
`and potentially toxic. As a protein cofaotor, iron can bind directly
`to amino acids, forming mono- or dinuclear iron centers, or it can
`be incorporated with porphyrins or sulfide to form home or Fe—S
`clusters, respectively. However, uncontrolled iron redox chem-
`istry can lead to formation of reactive oxygen species, causing
`extensive cellular and molecular damage that eventually leads to
`cell death (1). Therefore, cells must be able to sense iron levels and
`regulate iron homeostasis accordingly to maintain critical, non-
`toxic levels of this key nutrient.
`The expression of iron uptake and storage genes in the model
`eukaryote Sarcharomyces cereviriae is primarily controlled by the
`Fo—rcsponsive transcription factor Aftl. A01 is located in the
`cytosol under iron—replete conditions and moves to the nucleus
`
`TThis work was supporLed by the NIH (ESl3780. C.E.0.: GM62524,
`M.K.J,; GM47295, B.H.H.; l-IL13531, B.M.H.; P20 RR01646l, P.J.R,
`-G.) and by the Camille and Henry Dreyfus Foundation (Henry Dreyfus
`Teacher-Scholar Award to P.J.R.-G.). Both the National Synchrotron
`Light Source and the Stanford Synchrotron Radiation Laboratory are
`national user facilities supported by the US, Department of Energy.
`Office of Basic Energy Sciences. The SSRL Structural Molecular
`Biology Program is supported by DOE and the NlH-NCRR Biomedical
`Technolo
`Program.
`.
`*To w om correspondence should be addressed, C.E.0.: e-marl,
`caryn,outten@ehem.sc.edu; tel, 803-777-8783; fax. 803-777-9521. M.
`K}: e-mail, johnson@chem.uga.edu; tel, 706-542-9378; fax, 706-542-
`9454.
`
`© 2009 American Chemical Sou'ely
`
`under iron-depleted conditions, where it activates genes involved
`in high-affinity ionic iron uptake, siderophore iron uptake. and
`vacuolar
`iron transport, known collectively as
`the iron
`regulon (2—7). Nucleocytoplasmic shuttling of Aftl in yeast is
`regulated by mitochondrial Fe-S cluster biosynthcsis via a
`signaling pathway that includes the cytosolic monothiol glutar-
`edoxins (er3l and er4), the BolA homologue Fra2 (l~‘e
`repressor of activation—2), and the aminopeplidase P-like protein
`Fral (Fe repressor of activation-l) (8-11). When Fe-S cluster
`biosynthesis is active (i.e., under Fe replete conditions),
`this
`signaling pathway is proposed to induce multimerization ofA01
`in an unknown manner to promote its export from the nu-
`cleus (12), A 29‘CXCm motifis required for Aftl translocation in
`response to iron. but the specific function of these residues is
`unclear (2, I l, 12). Under low iron conditions or upon disruption
`of mitochondrial Fc-S cluster biogenesis, the FrallFroZ/er3/
`er4 pathway is shut off, allowing Aftl to accumulate in the
`nucleus and activate iron uptake systems. Despite the identifica-
`tion of multiple components in this signaling pathway,
`the
`
`‘Abbreviations: er. glutaredoxin: 'I‘rx, thioredoxin; GSH, reduced
`glutathione; GSSG, oxidized glutathione; MALDI—TOF. matrix-as-
`sisted laser desorption ionization-time of flight; CD, circular dichroism;
`EPR. electron paramagnetic resonance; ENDOR. electron-nuclear
`double resonance spectroscopy; EXAFS. extended X-ray absorption
`fine structure: IPTG. isopropyl fi-n-thiogalactoside; NSLS, National
`Synchrotron Light Source; SSRL, Synchrotron Radiation Laboratory:
`CN, coordination number; FT. Fourier transform.
`
`Published on Web 08/28/2009
`
`pubs.acsorg/Biochemistry
`
`
`
`

`

`9570 Biochemistry, Val. 48. Na. 40, 2009
`specific mechanism of iron—dependent regulation of Aftl locali-
`mtion by Fra2 and er3/4 is a key gap in our understanding of
`intracellular iron metabolism.
`Yeast er3 and er4 are members of the monothiol glutar-
`edoxin (er) family, which is found in organisms ranging from
`bacteria to humans. er3 and er4 are highly homologous
`proteins that possess both an N-terminal thioredoxin~ (Trx-) like
`domain and a C‘temtinal Grit-like domain (13). Cytosolic Grid
`and er4 perform redundant functions since deletion of each
`gene singly has little effect on iron regulation, while a grx3A
`grx4o double mutant exhibits constitutive expression of iron
`regulon genes (9, 10). The putative active site in the Grit—like
`domain of er3/4 has a highly conserved CGFS motif that is
`specifically required for interaction with Aftl and regulation ofits
`activity (9). A third CGFS’type monothiol Got in yeast (er5) is
`localized to mitochondria where it plays an essential but
`ill—defined role in mitochondrial Fe-S cluster biogenesis (14, 15).
`The human homologue of the yeast cytosolic monothiol ers
`(11er3, also known as PICOT for PKC—interacting cousin of
`Trx) was initially identified in T lymphocytes where it acts as a
`negative regulator of protein kinase 00 via an unknown mechan-
`ism (16). More recently, mammalian er3 was shown to inhibit
`cardiomyocytc hypertrophy (i.e.. thickening of the heart muscle)
`by binding to the muscle LlM protein (ML?) and blocking the
`stress-responsive. prohypertrophic caicineut‘in-nuclear factor of
`the activated T-txll (NFAT) signaling pathway (I7).
`ers are part of the Trx-fold superfamily and typically
`catalyze thiol—disulfide exchange reactions via monothiol or
`dithiol mechanisms ( I8). The dithiol mechanism requires two Cys
`in the active site (usually in a CPYC motif), with the N-terminal
`Cys forming a mixed disulfide between er and the target
`protein, which is resolved by the second active site Cys. The
`monothiol mechanism requires only the N-terminal Cys in the
`active site and is used for reducing mixed disulfides between GSH
`and target proteins. Although the N-terminal Cys is conserved in
`CGFS-type monothiol er, they lack oxidoreductase activity
`when tested with standard er model substrates (18). Several
`members ofthe monothiol ers family, including yeast er3 and
`er4. were recently shown to form [2Fe—25]~bridged homodimers
`with the CGFS active sites providing two Cys ligands (IO—~21).
`interestingly. two glutathione molecules (GSH or y—glutamyl—
`cysteinyiglycine) provide the other two cluster ligands. GSl-I is an
`abundant lripeptide that serves as the primary intracellular thiol
`redox buffer and a cofactor for glutaredoxins and other anti-
`oxidant enzymes (22). in the three published crystal structures of
`[2Fe-ZSl-bridged dithiol and monothiol er proteins, the GSH
`molecules are covalently linked to the cluster but held in place by
`noncovalent interactions with theGSH binding pocket in the Gut
`protein (2]. 23, 24). GSH seems to play a role in yeast er3/4
`function since GSH binding residues in er3/4 are essential for
`regulation of Aftl activity (9). Based on previous studies. several
`possible functions for monothiol ers in iron metabolism have
`been proposed. ers may act as scaffolds for Fe-S cluster
`assembly. delivery proteins for Fe-S cluster transfer, regulators
`of Fe-S cluster assembly, or Fe-Sdependent sensors that
`relay cellular
`iron status
`to iron-responsive transcription
`factors (19—21). In any case,
`the unusual GSH-ltgalecl Fe-S
`cluster in monothiol Grits directly links iron homeostasis wtth
`Fe-S cluster assembly and thiol redox regulation.
`,
`Several
`lines of evidence suggest that the monothiol ers
`function together with another widely conserved protein family,
`the BolA-lilte proteins (25). 301A was originally identified in
`
`Li et a1.
`
`Article
`
`Escherichia call as a protein that induces a round cell shape when
`overcxpresscd (26). Although BolA—like proteins are found in
`a wide variety of prokaryotes and eukaryotes, their specific
`molecular function is unknown. Genome-wide yeast two-hybrid
`assays have identified a physical interaction between cytosolic
`monothiol ers and BolA-like proteins in both S. cerevisiae and
`Drasaphila malanogaster (27, 28). In addition, proteome—wide
`FLAG— and TAP-tag affinity purification studies in yeast and
`E. cali have shown that BolA-like proteins such as Fra2 copurify
`with monothiol ers (29*31). The physical interaction between
`yeast er3/er4 and the BolA—iike protein Fra2 was recently
`confirmed by inununoprecipitation and split YFP tagging (8).
`Finally, comparative genomic analyses also predict a functional
`interaction between monothiol ers and BolA-like proteins
`since they are neighbors in several prokaryotic genomes (25).
`Furthermore. genes encoding the BolA and monothiol er
`proteins exhibit strong genome cooccurrence since almost all
`organisms that possess a BolA-like protein also have a CGFS
`monothiol er, while organisms that lack a BolA-like protein
`almost always lack a CGFS-type er (25, 32). Taken together,
`these data demonstrate a strong phylogenetic connection be-
`tween the two protein families. However.
`the nature of the
`interaction between CGFS-type ers and BolA—like proteins
`has not been previously determined
`This study is aimed at characterizing the interaction between
`yeast er3/4 and Fra2 in vitro using biochemical, spectroscopic,
`and analytical techniques. We show here that both er3 and
`er4 form [2Fe-ZS]-conlaining heterodimers with Fra2 that have
`similar Fe—S coordination environments. However, the UV—vi—
`sible absorption. CD.
`resonance Raman. EPR. ENDOR,
`Mossbauer, and EXAFS spectra of reconstituted [ZFe-ZS]-
`bridged er3 or er4 homodimers are markedly different from
`[2Fe-ZS] Fra2-Grit3/4 heterodimers,
`indicating differences in
`cluster coordination. Furthermore, we have determined that
`conserved residues required for er3 and er4 Fe signaling
`in vivo are also required for Fe-S complex formation with Fra2
`in vitro. This study thus provides new insight into the molecular
`details of intracellular Fe signaling and establishes the ubiquitous
`monothiol ers and BolAalike proteins as a novel type of Fe-S
`cluster binding regulatory complex.
`
`EXPERIMENTAL PROCEDURES
`Plasmid Construction. Construction of the yeast er3
`E. calf expression vector pET21a~er3 was described pre-
`viously (33), The ORF of yeast er4 were amplified from
`S. cerevisiae genomic DNA by PCR using the primers shown
`in Supporting Information Table l and cloned into the NdeI and
`Ele sites of pETZla (Novagen) to generate pETZla-er4.
`E. cult expression vectors for His—tagged Fral (pETZla-Fral-
`His.) and Fra2 (pET21a-Fra2-Hi56) were kindly provided by
`Jerry Kaplan (University of Utah) (8). The untagged Fra2
`expression vector pETZla»Fra2 was constructed by amplifying
`the Fra2 ORF without the His tag from pETZIa-FraZd-iisé and
`reinserting the gene at the Ndel and Sacl sites in pETZla (see
`printers in Supporting Information Table l). Fral-Hist. (from
`pETZla-Fral-Hise) and untagged Fra2 (from pET21a~Fra2)
`were subcloned into the first and second multiple cloning
`sites (Nail/Sari and Ndel/Kpnl) of the coexpression vector
`pRSFDueM (Novagen), respectively. to generate pRSFDuet~
`l~Fral-Hise/Fra2
`and pRSFDuet-l-Fral. er3 mutants
`were created by sitedirectod mutagenesis of pETZln-er3
`
`‘
`
`(QuikChange kit; Stratagene) using primers listed in Supporting
`Information Table 1. pETZla-er3(Al-121) was created by
`introducing an NdeI restriction site at position 122 in pETZla—
`er3 by site-directed mutagenesis, digesting the plasmid with
`Ndel to remove the coding sequence for amino acids 1—121, and
`religating the plasmid. pET21a-er3(A122-250) were created
`by introducing a stop codon and Hz'ndIII site at position 122,
`digesting the plasmid with HindlIl to remove the coding sequence
`for amino acids 122-250, and religating the plasmid. The cDNA
`for human er2 (herZ) (Open Biosystcms) was PCR amplified
`without the mitochondrial targeting signal (amino acids 41 — 164)
`and subclotied into pET24d (Novagcn) using the Neal and
`EcoRI restriction sites to make pET24d-her2. The sequence
`integrity ofall plasmids was continued by double—stranded DNA
`sequencing (Environmental Genomics Facility. University of
`South Carolina School of Public Health).
`Protein Expryssian and Purification. Recombinant er3
`and er4 were both purified using the previously published
`protocol for er3 (33). We note that recombinant er3 was
`cloned from the second start site (encoding Met36) to the stop
`codon after determining that the first start site (encoding Metl)
`was not utilized in viva (N. Dingra and C. Outten, unpublished
`data). The er3 amino acid sequence numbering in this study
`thus starts with the second start site as Metl. er3 (or er4) was
`coexprcsscd with Fral and Fra2 by transforming pETZla—erS
`(or pETZla-er4) and pRSFDuet-l—Frul-Hiss/FraZ into the
`E. cali strain BLZi (D133). Generally, a l L LB culture was grown
`with shaking at 30 °C and induced with 1 mM iscpropyl
`fi—D—thiogalactoside (IPTG) at ODfim 0.6—0.8. The cells were
`collected by centrifugation 18 h after induction and resuspended
`in 50 mM Tris—MES. pH 8.0,
`followed by sonication
`and centrifugation to remove the cell debris. The cell—free
`extract was loaded onto a DEAE anion-exchange column (GE
`Healthcare) equilibrated with 50 mM Tris-MES. pH 8.0.
`The protein was eluted with a salt gradient. and the fractions
`containing erft (or er4) and Fra2 were pooled and concen-
`trated to 2 mL. A fraction of Fra2 that was not bound to er3
`was also present in the DEAE flow-through and further purified
`as described below. (NH4J2804 was added to the FmZ-er3
`(or Fra2—er4) complex to a final concentration of 1 M, and
`the sample was loaded onto a phenyl-Sepharose column (GE
`Healthcare) equilibrated with 50 mM Tris—MES, pH 8.0,
`100 mM NaCl, and l M (NHs)ZSO4. The protein was then eluted
`with a decreasing (NH4)ZSO4 salt gradient, and the fractions
`containing er3 (or er4) and Fra2 were concentrated and
`loaded onto a HiLoad Superdex 75 gel filtration column (GE
`Healthcare) equilibrated with 50 mM Tris—MES, pH 8.0, and
`150 mM NaCl. The purest fractions ofthe Fm2—er3/4 complex
`as judged by SDS—PAGE were collected and concentrated to
`~250 yL with the addition of 5% glycerol and stored at 780 °C.
`Purification of Fra2-er3/4 was done aerobically: however, the
`procedure was completed in 1 day using degassed buffers to
`minimize loss of the Fe~S cluster.
`STE-labeled samples ofthe Fra2-er3 or Fm2.er4 complex
`for Mbssbauer studies were prepared by growing the E. Cali
`recombinant Fra2-er3 or Fra2-Grief coexpression strain in
`media supplemented with 57FeSO... One liter of cells was first
`grown at 30 °C in LB media to 013m ~06. then collected by
`centrifugation, and resuspended into 1 L of fresh M9 minimal
`media with 0.2% gluconate, The cells were grown at 30 °C for
`30 min; then ”Peso. and WTG were added at 50 pM and 1 mM
`final concentrations. respectively. The cells were collected by
`
`9571
`Biochemistry, Val. 48, No. 40, 2009
`centrifugation 18 11 after induction. Subsequent purification of
`i7Fe-labelcd FmZ-er3 or FraZ-er4 utilized the same protocol
`described in the previous paragraph.
`For purification of Fra2 without er3 or er4, BL21(DE3)
`E. coli cells were transformed with pETZla-Fraz. Fra2 expressed
`in this strain resides in inclusion bodies, thus requiring unfolding
`and subsequent refolding to purify. However, uncomplexed Fra2
`could be purified from the DEAE column flow-through from
`cells coexpressing er3 and F1112 as mentioned above. The Fraz-
`containing DEAE flownhrough fractions were adjusted to pH
`6.0 and loaded onto an SP FF cation-exchange column
`(GE Healthcare) equilibrated with 50 mM MES—Na, pH 6.0.
`Fra2 was eluted with a salt gradient, concentrated, and loaded
`onto a HiLoad Superdex 75 gel
`filtration column (GE
`Healthcare) cquilibrated with 50 mM Tl‘iS'MES. pH 8.0. and
`150 mM NaCl. The purest fractions of Fra2 were collected.
`concentrated to ~500 ”L with the addition of 5% glycerol, and
`stored at ~80 °C. The yield of uncomplexed Fra2 from the
`DEAE flow-through was highest when Fra2 was coexpressed
`with er3(Cl768) (see Results).
`Recombinant her2 was overexpressed in the E. call BL21-
`(DE3) strain and grown at 37 °C with shaking until ODm = 0,6.
`The cultures were cooled to 20 °C, and 1 mM IPTG was added to
`induce her2 expression. After overnight growth (~18 h) at
`room temperature, cells were harvested by centrifugation and
`stored at —80 °C. The cell pellet was subjected to three freeze—
`thaw cycles, and soluble protein was extracted with 50 mM Tris»
`lICI, pH 8.0. The protein was precipitated with 25r60“/u
`(NH4)2S04 and the pellet resuspended in 50 mM Tris-HCI, pH
`8.0, and subsequently loaded on a dcsalting column followed by a
`DEAE column (GE Healthcare) both equilibrated with 50 mM
`Tris-HCL pH 8.0. The majority of herZ did not bind to the
`DEAE column and was concated in the flow-through. These
`fractions were concentrated and loaded onto a HiLoad Superdex
`75 gel filtration column (GE Healthcare) equilibrated with
`50 mM Tris-HCl. pH 8.0, and 150 mM NaCl. [2Fe-ZS] herZ
`elutes as a dimer, while apo herZ elutes as a monomer as
`previously reported (34).
`In Vitro Fe-S Cluster Reconstitution an A110 er3 and
`er4. Reconstitution of an Fe-S cluster on apo er3, 1 mM in
`100 mM Tris-HCl buffer at pH 7.8, was carried under anaerobic
`conditions (02 < 5 ppm) in a glovebox (Vacuum Atmospheres,
`Hawthorne, CA). The reaction mixture involved 2 mM GSl—l, a
`16—fold excess of ferrous ammonium sulfate (”Fe—labeled for
`Mdssbauer samples) and L»cysteine, and catalytic amounts of
`Azotobacter vinelandii NifS (6.27luM) and was incubated at room
`temperature for 50 min. Reagents in excess were removed
`anaerobically by loading onto a High-Trap Q-Scpharosc column
`(GE Healthcare) inside the glovebox. Elution was achieved using
`a NaCl gradient with cluster-bound er3 eluting between 0.60
`and 0.70 M NaCl. Samples were pooled together as a single
`fraction before concentrating and desalting using Ainicon ultra—
`filtration with a YM10 membrane. The same protocol was
`followed for reconstituting an Fe-S cluster on apt) er4.
`Biochemical Analyses. Protein concentrations were deter—
`mined by the Bradford assay [Bio-Rad) using bovine serum
`albumin as the standard. Iron concentrations were determined
`using the colorimetric ferrozine assay (35). Acid—labile sulfur
`concentrations were determined using published methods
`(36, 37). For GSH measurements,
`the purified Fe~S protein
`complexes were denatured and precipitated with 1% 5-sulfosa-
`licylic acid. and GSH in the supernatant was measured by the
`
`
`
`

`

`9572 Biochemistry, Vol. 48, No. 40, 2009
`
`5,5'~dithiobis(2-nitrobenzoic acid)-GSSG reductase cycling
`assay as previously described (38).
`Analytical and Spectroscopic Methods. Analytical gel
`filtration analyses were performed on a Superdex 75 10/300
`GL column (GE Healthcare) equilibrated with 50 mM
`Tris—MES, pH 8.0. and 150 mM NaCl and calibrated with
`the low molecular weight
`gel
`filtration calibration kit
`(GE Healthcare). The buffer was bubbled with N2 overnight
`and degassed to minimize dissolved 02 levels. Elution profiles
`were recorded at 280 nm with a flow rate of 0.5 mL/min.
`UV—visible absorption spectra were recorded using a Beckman
`DU-SOO or Shimadzu [JV—310] spectrophotometer, and CD
`spectra were recorded on identical samples using a lasco J-715
`spectropolarimeter. Mass spectrometry analysis of purified pro—
`teins was determined using a Bruker UltraFlex MALDIaTOF/
`TOF mass spectrometer. A saturated solution ofsinapinic acid in
`50% acetonitrile and 0.1% m‘fluoroacetic acid was used as the
`matrix. and myoglobln and ubiquitin were the calibration
`standards. Resonant» Raman spectra were recorded as pre-
`viously described (39), using an Instruments SA Ramanor
`U1000 spectrometer coupled with a Coherent Sabre argon ion
`laser, with 20yL frozen droplets of l.5~2.6 mM sample mounted
`on the cold finger of an Air Products Displex Model CSA-ZOZE
`closed cycle refrigerator. X-band (~9.6 GHz) EPR spectra were
`recorded using a ESP-300D spectrometer (Bruker. Billeriw,
`MA), equipped with an ESR 900 helium flow cryostat (Oxford
`Instruments, Concord. MA). and quantified under nonsaturating
`conditions by double integration against a 1.0 mM CuEDTA
`standard. Q-band (~35 GHz) CW ENDOR experiments were
`carried out at 2 K using a spectrometer described previously (40).
`Massbauer spectra were recorded by using the previously de-
`scribed instrumentation (41). The zero velocity of the spectra
`refers to the centroid of a room temperature spectrum of a
`metallic Fe foil. Analysis of the Mossbauer data was performed
`with the WMOSS program (SEE Co.).
`X-ray absorption spectra were measured at
`the National
`Synchrotron Light Source (NSLS) beamline X3-B and at Stan-
`ford Synchrotron Radiation Laboratory (SSRL) beamlines 9-3
`and 7-3. Concentrated samples of the FraZ-er3/4 heterodimer
`were mixed with glycerol (final concentration 30% v/v glycerol
`and 1—2 mM Fe) and were frozen in a Lucite sample cell covered
`with Kapton tape. Spectra were collected at cryogenic tempera-
`tures using a helium displex cryostat at NSLS (30 K) or with an
`Oxford Instruments continuous flow liquid helium erysostat at
`SSRL (10 K). Beamlines were equipped with double crystal
`monochromators with Si[l ll] (NSLS) or Si[220] (SSRL) crystals.
`Harmonic rejection mirrors were used. and spectra were collected
`under fully tuned conditions. Canberra solid—state germanium
`detectors (13 element (NSLS) or 30 element (SSRL)) were used to
`detect the iron Ku fluorescence. Data points were collected every
`5 eV in the preedge region. every 0.25 eV in the edge region.
`and every 005 k in the EXAFS region. Scans were typically
`collected for 45 min, with data acquisition time increasing to 5 5
`per point at higher It. Each scan and detector element was
`examined for electronic anomalies and photoreduction effects
`before averaging 6—12 individual scans for analysis. Scans were
`individually calibrated by simultaneously measuring the spec-
`trum of an Fe foil. Scans were energy shifted such that the rising
`inflection of the Fe edge in the foil spectrum was 7111.2 eV.
`Though the Fra2~er3/4 samples were not readily photoreduced,
`we did observe minor shifts in edge energy from scan to scan. As a
`precaution, the beam size was reduced to 1 mm x 3 mm. and new
`
`scans were initiated at fresh locations of the sample surface. At
`this size. six fresh sample spots were monitored per sample.
`Replicate samples were measured with equivalent results.
`Data were processed using the Mac OS 10 version of EX-
`AFSPAK. a suite of data analysis programs available on the
`SSRL Web site. This program was interfaced to Fell‘7.2 to
`generate the theoretical scattering models used in the fits. The
`value of AEO was fixed to a value of ~10 eV and the scale factor
`was fixed at 0.9. values that yield the correct crystallographically
`determined bond lengths and coordination numbers for iron
`model complexes Bond length. R. and the Debye—Waller factor
`(02) were varied freely in each fit. Coordination numbers were
`incremented in fractional steps to refine the optimal number
`based on goodness offit, Fit quality wasjudged using a modified
`F value, F, that adjusts for the number ofvariables used in a fit.
`All fits reported here are to unfiltered data over a k range of l — 14
`A”. Both single scattering and multiple scattering models were
`used to fit the data. In the latter. parameters for an imidazole ring
`scatterer were used to model histidine ligands. For these fits, the
`Fe-N,,,,,d distance and 02 values were floating freely, and the
`other atoms in the imidazole ring were linked to the refined value
`Fe‘Nimid-
`
`RESULTS
`
`Fra2 and er3/4 Copurify as c Heteradimeric Complex.
`To characterize the interactions between Fro2, er3, and er4,
`the individual proteins were initially expressed and purified
`separately for in vitro analysis. Soluble recombinant er3 and
`er4 were easily extracted from E. coli yielding the apo,
`monomeric
`forms upon aerobic purification (Figure
`1,
`Table 1). However, recombinant FraZ was largely found in
`inclusion bodies and partially degraded upon purification
`(Figure I). The molecular mass of the purified proteins (with
`the first Met removed in each case) was continued by MALDI-
`TOF mass spectrometry (Table I). Since Fra2 interacts with Fral
`and er3/4 in vivo (8), we tested whether cocxprcssion of the
`interacting proteins improved the solubility of Fru2. Fral, Fra2,
`and er3 were cocxpressed using an E. coli strain cotrans-
`formed with one plasmid expressing Fral and FraZ and another
`expressing er3. After collecting the induced cells. we immedi-
`ately noted that the cell pellet was a reddish brown color that was
`not observed when the proteins were expressed separately.
`SDS~PAGE analysis showed that Fraz and er3 were both
`expressed at high levels. while the Fral protein was not visibly
`detectable (expected mass = 86.0 kDa with His tag) (Figure 1A).
`Furthermore, Fra2 and er3 were found to copurify as a reddish
`brown-colored complex with a higher apparent molecular mass
`than the individual proteins as determined by analytical gel
`filtration (Figure 13, Table 1). Similar results were obtained
`upon coexpression of Fra2 with er4. The reddish brown Fra2—
`er complex was also purified upon expression of Fra2—er3
`or Fra2-er4 without F

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket